ChemicalBook > CAS DataBase List > Suvizumab

Suvizumab

Product Name
Suvizumab
CAS No.
914257-21-9
Chemical Name
Suvizumab
Synonyms
Suvizumab;Research Grade Suvizumab;Research Grade Suvizumab (DVV03101)
CBNumber
CB58080812
Formula Weight
0
MOL File
Mol file
More
Less

Suvizumab Property

form 
Liquid
color 
Colorless to light yellow
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

Suvizumab Chemical Properties,Usage,Production

Uses

Suvizumab (KD-247) is an neutralizing antibody anti-HIV-1. Suvizumab effectively neutralizes HIV-1MN, HIV-1SF2 and HIV-189.6 with IC50 values of 0.1 μg/mL, 1.0 μg/mL and 0.2 μg/mL, respectively. Suvizumab reduces the viral load of HIV. Suvizumab has good tolerance and can be used to prevent HIV infection[1][2].

in vivo

Suvizumab (15, 30 and 45 mg/kg; i.v.; single dose) attenuates viral attack and plasma viremia, and increased the number of CD4+ T cells in SHIV C2/1 infected cynomolgus monkeys with dose-dependent manner[2].
Suvizumab (45 mg/kg; i.v.; once a week for 2 months) reduces the loss of CD4 T cells in lymphoid tissue in male cynomolgus monkeys infected with simian/human immunodeficiency virus-C2/1[4].

IC 50

HIV-1; HIV-189.6: 0.2 μg/mL (IC50); HIV-1MN: 0.1 μg/mL (IC50); HIV-1SF2: 1.0 μg/mL (IC50)

References

[1] Matsushita S, et al. Passive transfer of neutralizing mAb KD-247 reduces plasma viral load in patients chronically infected with HIV-1. AIDS. 2015 Feb 20;29(4):453-62. DOI:10.1097/QAD.0000000000000570
[2] Eda Y, et al. Anti-V3 humanized antibody KD-247 effectively suppresses ex vivo generation of human immunodeficiency virus type 1 and affords sterile protection of monkeys against a heterologous simian/human immunodeficiency virus infection. J Virol. 2006 Jun;80(11):5563-70. DOI:10.1128/JVI.02095-05
[3] Yoshimura K, et al. Resistance profile of a neutralizing anti-HIV monoclonal antibody, KD-247, that shows favourable synergism with anti-CCR5 inhibitors. AIDS. 2006 Oct 24;20(16):2065-73. DOI:10.1097/01.aids.0000247587.31320.fe
[4] Murakami T, et al. Postinfection passive transfer of KD-247 protects against simian/human immunodeficiency virus-induced CD4+ T-cell loss in macaque lymphoid tissue. AIDS. 2009 Jul 31;23(12):1485-94. DOI:10.1097/QAD.0b013e32832e5331

Suvizumab Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Suvizumab Suppliers

ShangHai Biochempartner Co.,Ltd
Tel
177-54423994 17754423994
Fax
QQ:2853530913
Email
2853530910@QQ.com
Country
China
ProdList
8000
Advantage
62
Guangzhou Hongyuan Chemical Co.,Ltd
Tel
15817493340
Email
981810490@qq.com
Country
China
ProdList
1566
Advantage
58
Wuhan Chemstan Biotechnology Co., Ltd.
Tel
027-65317797 15926423062
Fax
QQ:422450190
Email
422450190@qq.com
Country
China
ProdList
10308
Advantage
58
Biolab Reagents
Tel
027-65279366 18108604356
Email
products@biolabreagent.com
Country
China
ProdList
9868
Advantage
58
Wuhan Jingkangen Biomedical Technology Co., Ltd
Tel
13720134139 086-15871494362 13720134139
Email
orders@jknbiochem.com
Country
China
ProdList
6762
Advantage
58
Shanghai Yifei Biotechnology Co. , Ltd.
Tel
021-65675885 18964387627
Email
customer_service@efebio.com
Country
China
ProdList
11973
Advantage
58
Changsha Fuzhen Biotechnology Co.,LTD
Tel
0731-13823398 15111215862
Email
313359644@qq.com
Country
China
ProdList
4161
Advantage
58
Wanxin Biotechnology (Jiaxing) Co., LTD
Tel
0573-83568680 18057391398
Email
3956524501@qq.com
Country
China
ProdList
1442
Advantage
58
Atagenix Laboratories
Tel
027-87008169 17762441161
Email
info@atagenix.com
Country
China
ProdList
10001
Advantage
58
AntibodySystem Laboratories SAS
Tel
33175446423
Email
support@antibodysystem.com
Country
China
ProdList
6739
Advantage
58

914257-21-9, SuvizumabRelated Search:


  • Suvizumab
  • Research Grade Suvizumab (DVV03101)
  • Research Grade Suvizumab
  • 914257-21-9